TrialInvestigational new drugs2017

Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.

Satoshi Igawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.